Dr. Inga Böll

• Act as key contact point for business teams and manage the interface to R&D and Operations • Coordination of timelines / budgets for all respective programs • Manage execution of cross-functional decisions & plans and track progress of activities

Commercialization of the overall reagent line (IVD immuno assays) on Elecsys instrument platforms. • Drive post-launch activities for the new e pack green reagent line including coordination of business relevant activities across the entire Elecsys line • Management of cross business team topics and cross functional projects

Responsible for commercial development of Pharma QC and Cell Therapy portfolio. Definition and implementation of marketing and branding strategy. Portfolio planning (Lifecycle management). Alignment with regions. Set-Up of Strategy and Business Cases. • Developed new messaging concept and successfully supported APAC Sales organization • Initiated and established strategic cooperations with internal and external partners

Fully responsible for a market segment (cell therapy, stem cells), incl. introduction of new products and portfolio strategy. Development of marketing strategy and business plan. Alignment with regions. • Ensured commercial development of the Cell Therapy market segment (30% growth in 2012)

Introduction of a new brand (Custom Biotech). Coordination of all marketing activities and creation of promotion materials. Market analyses and identification of new markets. • Planned, prepared and executed launch of the new brand in fewer than 6 months • Increased Brand awareness and marketability of the Roche B2B business

Establishment and leadership of a regional customer support center: Next Generation Sequencing. Definition and establishment of processes and alignment with country managers. Handling of customer complaints. Design and implementation of internal and customer trainings in AsiaPacific. • Built a cross-border team of Application Specialists, Engineers and Bioinformatic Specialists

Conducting of internal and external trainings for the Genome Sequencer. Establishment of 1st and 2nd level support in EMEA, LATAM and APAC. Implementation of new processes. Development of training material (Quick Guides, Multimedia, Poster). Handling of customer complaints. • Introduced a completely new technology to the market (Next Generation Sequencing)

Responsibility for quality of system reagents for the ElecSys instrument (heterogeneous and homogeneous immunoassays). Quality control, product enhancement and change management.

Rapid development and patenting of LightCycler Kits for multiplex applications (EP 1 634 965 A1). • Singlehandedly launched this product on a global scale during a Marketing internship • Conducted due diligence experiments in USA (454 Life Sciences), leading to an acquisition • Completed the Management Start-Up Program in fewer than three years

Performance of diagnostic measurements for detection of minimal residual disease. Performance of mRNA isolation, RT-PCR and Real-Time PCR of bone marrow samples. Coordination of lab technicians and guidance of interns (PhD students). Identification of new mutations and establishment of new diagnostic assays. • Identified several mutations potentially relevant to leukemia and published results in Blood and JBC

Dissertation: Prion diseases and oxidative stress in different transgenic mouse strains • Finished the PhD program ahead of schedule: University of Goettingen (Jun 1999 – Jun 2000) and University of Munich (Jul 2000 - Dec 2001) • Established the infectious lab area at University of Munich

Dissertation: Prion diseases and oxidative stress in different transgenic mouse strains • Finished the PhD program ahead of schedule: University of Goettingen (Jun 1999 – Jun 2000) and University of Munich (Jul 2000 - Dec 2001)

Biochemistry, Biophysical Chemistry, Virology